Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined measurement of anti-CCP and serum amyloid A to assess rheumatoid arthritis

Combined measurement of anti-CCP and serum amyloid A to assess rheumatoid arthritis

US Patent 7981693 · Granted Jul 19, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stro2025
Binding agent and assay for PIVKA2025
Detection of anti-p53 antibodies2025
Detection of anti-p53 antibodies2024
Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protei2024
IGFBP-7 as a marker of preeclampsia2024
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fi2023
Binding agent and assay for PIVKA2022
IGFBP7 for prediction of risk of AKI when measured prior to surgery2022
IGFBP7 for diagnosing diastolic dysfunction2021
Use of DPPIV/seprase as a marker for cancer2020
Biomarkers for risk prediction of mortality2020